ArticleFrontiers in immunology2025
Intestinal microbiota regulates naïve lymphocyte migration in Peyer's patches.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Germinal center responses at barrier organ sites.Current opinion in immunology · 2026Review
- The Gut-Vagina Axis.Microorganisms · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peyer's patches (PPs) are lymphoid organs in the small intestine that serve as inductive sites for both humoral and cellular immune responses against the microbiota, food antigens and pathogens. PPs in germ-free mice are small and hypocellular, highlighting the importance of the microbiota in regulating PP size. However, it is unclear whether this regulation reflects changes in immune cell activation and germinal center responses or alterations in lymphocyte migration kinetics. In this study, we modified the composition and density of the microbiota using antibiotics to investigate the corresponding changes in PP cellularity. We demonstrated that distinct microbiota compositions can result in a reduction in PP size. This reduction was limited to PPs in the distal small intestine, and it reached germ-free levels after only three days of antibiotic treatment. Reduction in PP size was largely due to changes in lymphocyte circulation kinetics in PPs. Lymphocyte egress blockade using the functional S1PR1 antagonist FTY720 prevented the antibiotic-induced decrease in PP cellularity and the entry of naïve lymphocytes into PPs was reduced in antibiotic-treated mice. Our findings uncover a previously unrecognized role for the microbiota in regulating the migration of naïve lymphocytes into PPs, which has implications for the modulation of adaptive immune responses in the intestine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.